The RestoreD Study is a clinical research study evaluating an oral investigational medication, ALXN2050, that may help participants manage their Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) symptoms.
To learn more and to see if you may qualify, talk to your doctor or click the link below.
